Cipla (BOM:500087) EBIT per Share : ₹76.67 (TTM As of Sep. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cipla EBIT per Share?

Cipla's EBIT per Share for the three months ended in Sep. 2024 was ₹22.33. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹76.67.

During the past 12 months, the average EBIT per Share Growth Rate of Cipla was 19.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was 18.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 21.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cipla's EBIT per Share or its related term are showing as below:

BOM:500087' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -7.2 Med: 14.4 Max: 23.9
Current: 18.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cipla was 23.90% per year. The lowest was -7.20% per year. And the median was 14.40% per year.

BOM:500087's 3-Year EBIT Growth Rate is ranked better than
66.63% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs BOM:500087: 18.20

Cipla's EBIT for the three months ended in Sep. 2024 was ₹18,045 Mil.

Cipla EBIT per Share Historical Data

The historical data trend for Cipla's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla EBIT per Share Chart

Cipla Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

29.33

42.65

44.56

51.17

71.45

Cipla Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															20.06	18.62	15.57	20.16	22.33

Cipla EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cipla's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	57730.3	/	807.999
=	71.45

Cipla's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	18044.6	/	808.021
=	22.33

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹76.67

Cipla (BOM:500087) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cipla EBIT per Share Related Terms

Thank you for viewing the detailed overview of Cipla's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CIPLA:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines